Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

Fig 8

Forest plot of the relative risks for AML progression in case group (lenalidomide-treated) and control group (lenalidomide-untreated).

Fig 8

doi: https://doi.org/10.1371/journal.pone.0165948.g008